Research Article
PPARG: A Promising Therapeutic Target in Breast Cancer and Regulation by Natural Drugs
Table 1
PPARG expression levels in BC patients in relation to clinicopathological characteristics.
| | Clinicopathological characteristics | High expression group | Low expression group | -Value |
| Status | Alive | 480 | 467 | 0.333 | Dead | 71 | 83 | Age | Mean (SD) | 57.6 (13) | 59.1 (13.4) | 0.069 | Median [Min, Max] | 58 [26, 90] | 59 [26, 90] | Gender | Female | 546 | 543 | 0.769 | Male | 5 | 7 | pT-stage | TX | 0 | 3 | 0.007 | T1 | 161 | 120 | T2 | 292 | 347 | T3 | 83 | 55 | T4 | 15 | 25 | pN-stage | NX | 7 | 13 | 0.173 | N0 | 252 | 264 | N1 | 187 | 179 | N2 | 56 | 64 | N3 | 49 | 30 | pM-stage | MX | 86 | 77 | 0.182 | M0 | 455 | 455 | M1 | 7 | 15 | pTNM-stage | X | 5 | 8 | 0.041 | I | 102 | 80 | II | 296 | 328 | III | 136 | 115 | IV | 6 | 14 |
|
|